Cargando…
Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
BACKGROUND: Relapsed/refractory high-risk neuroblastoma has a dismal prognosis. Anti-GD2-mediated chemo-immunotherapy has a notable anti-tumor activity in patients with relapsed/refractory high-risk neuroblastoma. The purpose of this study was to analyze the efficacy and safety of the combination of...
Autores principales: | Olgun, Nur, Cecen, Emre, Ince, Dilek, Kizmazoglu, Deniz, Baysal, Birsen, Onal, Ayse, Ozdogan, Ozhan, Guleryuz, Handan, Cetingoz, Riza, Demiral, Ayse, Olguner, Mustafa, Celik, Ahmet, Kamer, Serra, Ozer, Erdener, Altun, Zekiye, Aktas, Safiye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816792/ https://www.ncbi.nlm.nih.gov/pubmed/36620564 http://dx.doi.org/10.3389/fonc.2022.1041443 |
Ejemplares similares
-
Radiological staging in neuroblastoma: computed tomography or magnetic resonance imaging?
por: Sarioglu, Fatma C., et al.
Publicado: (2019) -
Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients
por: Baran, Burçin, et al.
Publicado: (2023) -
Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity
por: Aktaş, Tekincan Çağrı, et al.
Publicado: (2023) -
Giant Congenital Sialolipoma of Parotid Gland with Parapharyngeal Extension
por: Erdağ, Taner-Kemal, et al.
Publicado: (2019) -
A Case of Central Precocious Puberty Due to Concomitant Hypothalamic Hamartoma and Juvenile Pilocytic Astrocytoma
por: Çatlı, Gönül, et al.
Publicado: (2014)